Wells Fargo & Company Issues Pessimistic Forecast for iTeos Therapeutics (NASDAQ:ITOS) Stock Price
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its price target cut by equities research analysts at Wells Fargo & Company from $19.00 to $17.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of […]
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its price target cut by equities research analysts at Wells Fargo & Company from $19.00 to $17.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of […]
